Safeguard Scientifics Inc. (NYSE:SFE) CEO Stephen T. Zarrilli purchased 3,900 shares of the firm’s stock in a transaction dated Wednesday, September 14th. The stock was acquired at an average price of $12.75 per share, for a total transaction of $49,725.00. Following the purchase, the chief executive officer now owns 103,606 shares in the company, valued at approximately $1,320,976.50. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink.

Safeguard Scientifics Inc. (NYSE:SFE) opened at 12.94 on Tuesday. Safeguard Scientifics Inc. has a 52 week low of $11.40 and a 52 week high of $18.07. The company’s market cap is $261.70 million. The stock has a 50 day moving average price of $13.79 and a 200 day moving average price of $13.26.

Safeguard Scientifics (NYSE:SFE) last released its earnings results on Thursday, July 28th. The company reported $1.92 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.47 by $0.45. During the same period in the prior year, the business earned ($0.91) earnings per share. On average, equities analysts forecast that Safeguard Scientifics Inc. will post $0.24 earnings per share for the current year.

Several institutional investors have recently added to or reduced their stakes in SFE. First Manhattan Co. raised its position in shares of Safeguard Scientifics by 0.5% in the second quarter. First Manhattan Co. now owns 1,693,363 shares of the company’s stock valued at $21,150,000 after buying an additional 8,605 shares during the period. Foundry Partners LLC raised its position in shares of Safeguard Scientifics by 0.3% in the second quarter. Foundry Partners LLC now owns 166,794 shares of the company’s stock valued at $2,083,000 after buying an additional 475 shares during the period. Keane Capital Partners LLC purchased a new position in shares of Safeguard Scientifics during the first quarter valued at $1,132,000. Legal & General Group Plc raised its position in shares of Safeguard Scientifics by 22.8% in the first quarter. Legal & General Group Plc now owns 44,528 shares of the company’s stock valued at $589,000 after buying an additional 8,260 shares during the period. Finally, Renaissance Technologies LLC raised its position in shares of Safeguard Scientifics by 216.0% in the first quarter. Renaissance Technologies LLC now owns 94,800 shares of the company’s stock valued at $1,256,000 after buying an additional 64,800 shares during the period. 78.61% of the stock is owned by institutional investors.

Separately, Zacks Investment Research lowered Safeguard Scientifics from a “buy” rating to a “hold” rating in a research note on Thursday, June 30th.

About Safeguard Scientifics

Safeguard Scientifics, Inc provides capital, as well as strategic, operational and management resources to growth-stage businesses. The Company participates in early- and growth-stage financings. The Company operates through two segments: Healthcare and Technology. The Healthcare segment’s companies focuses principally on medical technology (MedTech), including diagnostics and devices, and healthcare technology (HealthTech).

5 Day Chart for NYSE:SFE

Receive News & Ratings for Safeguard Scientifics Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Safeguard Scientifics Inc. and related companies with MarketBeat.com's FREE daily email newsletter.